AzTrials
AzTrials

BurnsNCT01828541

Hypnosis for Pain and Itch Following Burn Injuries

A study testing Hypnosis in people with Burns, run by University of Washington at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether hypnosis will decrease the intensity of either pain or itch in patients who have sustained a burn injury. Primary hypothesis: Hypnosis will provide more effective relief from post-burn itch and pain than a control intervention at 1-month, 3-months, 6-months and 1-year… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Burns
What is being tested?
Hypnosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
May 2013to Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18-65 years old
  • Ability to provide informed consent for study participation
  • ability to read and understand English
  • Undergoing pharmacologic therapy for burn related itch according to the standard itch protocol
  • Scoring of 4 out of 10 on the Numerical Rating Scale for average itch or pain

Who cannot join

  • Age less than 18 or greater than 65
  • Inability to provide informed consent
  • Inability to read or understand English
  • Delirium
  • History of mania, paranoia, dissociation and current suicidal ideation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Harborview Medical Center

    Seattle, Washington, 98104

Other trials in United States

About this study

Official title: A Randomized Controlled Trial of Hypnosis for Pain and Itch Following Burn Injuries

The purpose of this study is to determine whether hypnosis will decrease the intensity of either pain or itch in patients who have sustained a burn injury. Primary hypothesis: Hypnosis will provide more effective relief from post-burn itch and pain than a control intervention at 1-month, 3-months, 6-months and 1-year post-burn injury.

Secondary hypothesis 1: Subjects treated with hypnosis will report better sleep quality and fewer symptoms of Post Traumatic Stress Disorder (PTSD).

Read more

Secondary Hypothesis 2: Subjects treated with hypnosis will require less escalation of the gabapentin doses and have lower average pain scores than those in the control group.

Exploratory Hypothesis: Subjects who will randomize to the hypnosis treatment group early after injury will report lower rates of neuropathic pain and itch than subjects who will be enrolled in the study and receive hypnosis later in the healing process.

Read the detailed description

This is a randomized, controlled study comparing two groups of subjects, those in the control (standard care) group and those in the experimental group (hypnosis).

Control subjects will receive treatment as usual, which consists of a standardized protocol for treating post-burn itch. This protocol is based on past research and combines medications in a stepped approach that establishes therapeutic decisions based on clearly defined criteria.

Subjects randomized to the experimental group will undergo four sessions of live hypnosis completed over a two month period. They will be provided with a Compact Disk (CD) of each session and instructed to listen to it daily. Post-hypnotic suggestions will address uncomfortable sensations, with additional suggestions for improved sleep and well-being. Subjects may be inpatient or outpatients.

Conditions
Burns
Being tested
Hypnosis, Standard of Care
Keywords
Burn injuries
Medical subject headings
Burns

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HypnosisBehavioural

    Patients in this group will receive standard care plus 4 sessions of hypnosis.

  • Standard of CareOther

Study groups in NCT01828541
Study groupRoleWhat they receive
Standard CareOtherSubjects in this condition will receive our standard care for itch, which includes a stepped based algorithm of medications.
Receives: Other: Standard of Care
Hypnosis ConditionExperimentalSubjects in this condition will receive standard care plus the addition of 4 sessions of hypnosis delivered over a two month period.
Receives: Behavioral: Hypnosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Numerical Rating Scale for Average Itch

    Subjects will be asked to rate their average itch intensity over the previous 24-hour period using the 0 (no itch) to 10 (worst itch imaginable) scale. Change in this measures over time will be assessed.

    Measured: 48 hours, 1-, 3-, 6-, 12- months post-randomization

Secondary outcomes (5)
  1. Change in Numerical Rating Scale for Pain

    Subjects will be asked to rate their average pain intensity over the past 24 hours using the 0(no pain) to 10 (worst pain imaginable) scale. Change in this measure over time will be assessed.

    Measured: 48 hours, 1-. 3-. 6-, 12-months post-randomization

  2. Change in Medical Outcomes Study of Sleep

    This tool measures six different sleep constructs. We will use the 9-item sleep problem index score. Change in this measure over time will be assessed.

    Measured: 1-, 3-, 6-, 12-months post-randomization

  3. Change in Leeds Assessment of Neuropathic Symptoms and Signs-Self report

    A self report scale that is aimed at identifying neuropathic pain without the need for clinical examination. Change in this measure over time will be assessed.

    Measured: 1-, 3-, 6-, 12-months post randomization

  4. Change in 5-D Itch Scale

    Addresses the impact of itch over the previous two week period of time. Change in this measure over time will be assessed.

    Measured: 1-, 3-, 6-, 12 months post randomization

  5. Change in Post-Traumatic Stress Disorder Checklist-Civilian version

    A 17-item scale that measures each of the Diagnostic and Diagnostic and Statistical Manual-IV (DSM-IV) symptoms of Post Traumatic Stress Disorder (PTSD). Change in this measure over time will be assessed.

    Measured: 1-, 3-, 6-, 12-month post-randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2013 (estimated)
  2. Study startMay 2013
  3. Primary completionSep 2017 (estimated)
  4. Study completionSep 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01828541
Sponsor's protocol ID
STUDY00000542
Status last verified
May 2017
First submitted
29 Mar 2013
Last updated
12 May 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis in people with Burns, run by University of Washington at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Numerical Rating Scale for Average Itch (time frame: 48 hours, 1-, 3-, 6-, 12- months post-randomization). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in